Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) gapped up prior to trading on Monday following insider buying activity. The stock had previously closed at $36.45, but opened at $39.98.

Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) have been given an average recommendation of “Buy” by the six ...

TIMOTHY A SPRINGER, a director at $TECX, bought 660,000 shares of the company on 02-05-2025 for an estimated $33,000,000. This trade was reported by Quiver ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Tectonic Therapeutic (TECX – Research Report), with a ...

Strategic Investment Report for TD Global Technology Leaders CAD Hedged Index ETF (TECX) Highlighting Buy and Sell Opportunities ...

TECX stock reached a new 52-week high this week, with shares trading at an impressive $53.6. According to InvestingPro data, analysts maintain a strong buy consensus with price targets ranging from ...

Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

Analyst David Risinger from Leerink Partners reiterated a Buy rating on Tectonic Therapeutic (TECX – Research Report) and increased the price ...

Investment Strategy and Analysis for TD Global Technology Leaders CAD Hedged Index ETF (TECX) with Buy/Sell Signals ...

WATERTOWN, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), today announced that it has entered into a securities purchase agreement for a ...